Evaluation of candidemia risk factors and Candida species distribution in intensive care units among patients with and without COVID-19

Basit Öğe Kaydı
dc.authoridAlkan, Sevil / 0000-0003-1944-2477
dc.contributor.authorUyar, Cemile
dc.contributor.authorYıldız, Emel
dc.contributor.authorGenç, Özlem
dc.contributor.authorAk, Öznur
dc.contributor.authorKoçak, Emel
dc.contributor.authorAlkan, Sevil
dc.contributor.authorBalcı, Canan
dc.date.accessioned2025-01-27T20:47:44Z
dc.date.available2025-01-27T20:47:44Z
dc.date.issued2024
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjectives: To assess the risk variables related to the types of candidemia for each patient, who was admitted into the intensive care unit regardless of the patient with or without complete diagnosis of COVID-19, during the period of March 2019 to December 2022. Methods: The evaluation comparison of demographic and clinical data of COVID-19 positive and negative patients with candidemia confirmed in blood, 113 cases were assessed. Variables such as gender, age, age of hospitalization, history of hospitalization, concurrently infection, The acute physiology and chronic health evaluation -II scores, comorbidity checking, intubation, central venous catheter use, parenteral nutrition use, steroid use, antibiotic use, lymphopenia, and laboratory variables were evaluated. Candida species distribution, antifungal susceptibility in blood culture were determined. Results: Coronavirus disease -19 was present in 62.8% of cases confirmed candidemia, and these cases were significantly different from COVID-19 negative cases. Significance was found in more intubation, central venous catheter use, parenteral nutrition, and steroid therapy in Group 2. There was no significance with species distribution and associated infection. In total, COVID-19 positive had higher hemoglobin, aspartate aminotransferase, alanine transaminase, and white blood cell levels, which may be associated with the possibility of revealing and controlling candidemia. Conclusion: Candida albicans and Candida Parapsilosis ( C. parapsilosis ) are the species seen in infected COVID-19 patients, while C. parapsilosis and Candida tropicalis are found in non-COVID-19 ones. Risk factors were intubation, parenteral nutrition, central venous catheter, and steroid in the COVID-19 group.
dc.identifier.doi10.15537/smj.2024.45.6.20240102
dc.identifier.endpage616
dc.identifier.issn0379-5284
dc.identifier.issn1658-3175
dc.identifier.issue6
dc.identifier.pmid38830660
dc.identifier.scopus2-s2.0-85195002134
dc.identifier.scopusqualityQ2
dc.identifier.startpage606
dc.identifier.urihttps://doi.org/10.15537/smj.2024.45.6.20240102
dc.identifier.urihttps://hdl.handle.net/20.500.12428/25028
dc.identifier.volume45
dc.identifier.wosWOS:001244179000010
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSaudi Med J
dc.relation.ispartofSaudi Medical Journal
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectCOVID-19
dc.subjectcandidemia
dc.subjectrisk factors
dc.subjectintensive care unit
dc.subjectcross infection
dc.titleEvaluation of candidemia risk factors and Candida species distribution in intensive care units among patients with and without COVID-19
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Sevil Alkan_Makale.pdf
Boyut:
666.28 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu